APG-115 in Patients With Advanced Solid Tumors or Lymphomas

NCT02935907 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

50

Enrollment

INDUSTRY

Sponsor class

Conditions

Patients With Advanced Solid Tumor or Lymphoma

Interventions

DRUG: APG-115

Sponsor

Ascentage Pharma Group Inc.